Furthermore, to investigate the induction of MET in cancer cells after a single administration of eribulin, we obtained tumor specimens from the xenografts on day 7 and examined the expression of E-cadherin and vimentin by immunohistochemical analysis. This evidence concerns the gene CDH1 and neoplasm.